Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -68.57% and 68.81%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...

Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $34.5 million in its fourth quarter. On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 59 cents. The ...

Reports Q4 revenue $$6.278M, consensus $16.58M.” Over the past year, Voyager has significantly advanced our two wholly-owned programs targeting ...

A mediator was unable to help Unifor Local 3019 make any progress in contract negotiations after the employer, global commodities giant Trafigura, refused to back down from aggressive proposals to ...

Science correspondent Allan Blackman joins Kathryn to talk about a new part of the immune system that's been discovered and how it could be a goldmine of potential antibiotics. NASA has switched off ...

Stock futures are up in the first hour of evening trading, with S&P 500 gaining 0.3% and Nasdaq 100 up 0.4%.  Investors are looking ...

Pomerantz LLP is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...

The twin spacecraft launched in 1977 and are currently in interstellar space, or the space between stars. Voyager 1 ...

Palantir is expanding its AI footprint by partnering with Voyager Technologies to enhance space security. The collaboration ...